Amur Minerals Corporation (“Amur” or the “Company”), which has been reclassified as an AIM Rule 15 cash shell, is pleased to announce that further to the announcement of 4 March 2024, the Company has now executed a sale and purchase agreement (“SPA”) to conditionally acquire the entire issued and to be issued share capital of Extruded Pharmaceuticals Limited (“Extruded Pharmaceuticals” or “EPL”), a UK-based drug delivery technology company which is focused on improving the performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs (the “Proposed Transaction” or “Acquisition”).